Efficacy of a Dietary Supplementation With Lactobacillus Reuteri for Digestive Health in an Elderly Population

NCT01837940 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 290

Last updated 2014-12-05

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of a daily supplement consisting of the probiotic bacteria, Lactobacillus reuteri, on the digestive health among persons 65 years and older.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

Galactooligosaccharide (GOS) and rhamnose in a powder formulation

DIETARY_SUPPLEMENT

Lactobacillus reuteri DSM 17938

Lactobacillus reuteri DSM17938, Galactooligosaccharide (GOS), rhamnose in a powder formulation

Sponsors & Collaborators

  • BioGaia AB

    collaborator INDUSTRY
  • Örebro University, Sweden

    lead OTHER

Principal Investigators

  • Robert Jan Brummer, MD, PhD · Örebro Universitet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01837940 on ClinicalTrials.gov